Announcements
- Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
- Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
- Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
- Certara to Participate in the Jefferies Global Healthcare Conference
- Certara Appoints New Chief Human Resources Officer & General Counsel
- Certara Reports First Quarter 2024 Financial Results
- Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
- Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
- Certara Reports Fourth Quarter 2023 Financial Results
- Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
More ▼
Key statistics
As of last trade Certara Inc (CERT*:MEX) traded at 265.52, 0.00% above its 52-week low of 265.52, set on Sep 06, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 265.52 |
Low | 265.52 |
Bid | -- |
Offer | -- |
Previous close | 286.43 |
Average volume | 0.00 |
---|---|
Shares outstanding | 160.84m |
Free float | 119.66m |
P/E (TTM) | -- |
Market cap | 2.66bn USD |
EPS (TTM) | -0.3857 USD |
Data delayed at least 20 minutes, as of Sep 06 2022 12:30 BST.
More ▼